344
A. Zakharov and A. Lagunin
Action on antitarget
Related side effects
5HT 2A receptor antagonist
Hypnotic; Sedative
5-HT 2C receptor antagonist
Obesity; Weight loss
Alpha 1a adrenergic receptor antagonist
Dizziness; Flushing; Impotence; Nasal congestion;
Postural (orthostatic) hypotension; Tachycardia;
Weakness
Alpha 1b adrenergic receptor antagonist
Ejaculation dysfunction
Alpha 2a adrenergic receptor antagonist
Anxiety; Depression
Androgen receptor antagonist
Virilization; gynecomastia; hepatic pelioza;
hepatoma
Carbonic anhydrase inhibition
Acidosis, metabolic; Alopecia (hair loss); Anaphylaxis; Anemia, aplastic; Anxiety; Bone marrow
suppression; Chronic fatigue syndrome; Confusion;
Corneal edema; Depression; Dyspepsia; Dysphagia;
Impotence; Irritation; Keratitis; Malaise; Nausea;
Nephrotoxic; Neuroprotector; Paralysis; Pulmonary
edema; Renal tubular acidosis; Stevens-Johnson
syndrome; Taste disturbance; Thrombocytopenia;
Urinary stone; Vision blurring; Weight loss
Estrogen receptor antagonist
Depression; Headache; Obesity; Sickness; Hot
flashes; Puffiness
Delta-type opioid receptor antagonist
Reverse analgesia; Opioid withdrawal symptoms
MAO A inhibitor
Blood pressure lability; Bradycardia; Chorea;
Convulsions; Delirium; Diarrhea; Hepatotoxicity;
Drowsiness
Mu-type opioid receptor antagonist
Laxative
Sodium- and chloride-dependent GABA
transporter 1 inhibitor
Neurotoxicity
Sodium-dependent dopamine transporter
inhibitor
Neurotoxicity
Sodium-dependent serotonin transporter
inhibitor
Acute respiratory distress syndrome (ARDS);
Agitation; Akathisia; Anorgasmia; Antialcoholic;
Constipation; Convulsant; Diarrhea; Dizziness;
Drowsiness; Dysesthesia; Dyskinesia; Dystonia;
Ecchymosis; Ejaculation dysfunction; Emetic;
Epistaxis; Exanthema; Extrapyramidal effect; Glaucoma; Hallucination, visual; Headache; Hemorrhage; Hepatotoxic; Hormone secretion (SIADH);
Hot flush; Hyperprolactinemia; Hypersexuality; Hypertensive; Hypoglycemic; Hypomania;
Hyponatremia; Hypothermic; Insomnia; Ischemic
colitis; Mania; Menorrhagia; Myoclonus; Nausea;
Neuroleptic malignant syndrome; Panic; Parkinsonism; Purpura; QT interval prolongation; Serotonin
syndrome; Sexual dysfunction; Shivering; Sleep
disturbance; Stevens-Johnson syndrome; Sweating;
Syncope; Taste disturbance; Thrombocytopenia;
Tremor; Weight gain; Weight loss; Xerostomia
Table 11.10 Relationships between drug action on antitargets and adverse side effects from
PharmaExpert
A. Zakharov and A. Lagunin
Action on antitarget
Related side effects
5HT 2A receptor antagonist
Hypnotic; Sedative
5-HT 2C receptor antagonist
Obesity; Weight loss
Alpha 1a adrenergic receptor antagonist
Dizziness; Flushing; Impotence; Nasal congestion;
Postural (orthostatic) hypotension; Tachycardia;
Weakness
Alpha 1b adrenergic receptor antagonist
Ejaculation dysfunction
Alpha 2a adrenergic receptor antagonist
Anxiety; Depression
Androgen receptor antagonist
Virilization; gynecomastia; hepatic pelioza;
hepatoma
Carbonic anhydrase inhibition
Acidosis, metabolic; Alopecia (hair loss); Anaphylaxis; Anemia, aplastic; Anxiety; Bone marrow
suppression; Chronic fatigue syndrome; Confusion;
Corneal edema; Depression; Dyspepsia; Dysphagia;
Impotence; Irritation; Keratitis; Malaise; Nausea;
Nephrotoxic; Neuroprotector; Paralysis; Pulmonary
edema; Renal tubular acidosis; Stevens-Johnson
syndrome; Taste disturbance; Thrombocytopenia;
Urinary stone; Vision blurring; Weight loss
Estrogen receptor antagonist
Depression; Headache; Obesity; Sickness; Hot
flashes; Puffiness
Delta-type opioid receptor antagonist
Reverse analgesia; Opioid withdrawal symptoms
MAO A inhibitor
Blood pressure lability; Bradycardia; Chorea;
Convulsions; Delirium; Diarrhea; Hepatotoxicity;
Drowsiness
Mu-type opioid receptor antagonist
Laxative
Sodium- and chloride-dependent GABA
transporter 1 inhibitor
Neurotoxicity
Sodium-dependent dopamine transporter
inhibitor
Neurotoxicity
Sodium-dependent serotonin transporter
inhibitor
Acute respiratory distress syndrome (ARDS);
Agitation; Akathisia; Anorgasmia; Antialcoholic;
Constipation; Convulsant; Diarrhea; Dizziness;
Drowsiness; Dysesthesia; Dyskinesia; Dystonia;
Ecchymosis; Ejaculation dysfunction; Emetic;
Epistaxis; Exanthema; Extrapyramidal effect; Glaucoma; Hallucination, visual; Headache; Hemorrhage; Hepatotoxic; Hormone secretion (SIADH);
Hot flush; Hyperprolactinemia; Hypersexuality; Hypertensive; Hypoglycemic; Hypomania;
Hyponatremia; Hypothermic; Insomnia; Ischemic
colitis; Mania; Menorrhagia; Myoclonus; Nausea;
Neuroleptic malignant syndrome; Panic; Parkinsonism; Purpura; QT interval prolongation; Serotonin
syndrome; Sexual dysfunction; Shivering; Sleep
disturbance; Stevens-Johnson syndrome; Sweating;
Syncope; Taste disturbance; Thrombocytopenia;
Tremor; Weight gain; Weight loss; Xerostomia
Table 11.10 Relationships between drug action on antitargets and adverse side effects from
PharmaExpert
